Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site lymphadenopathy
Clinical narrative: axillary swelling in the arm where he receive the injection; left arm  axillary painful, tiny lymph node; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (axillary swelling in the arm where he receive the injection) and PAIN IN EXTREMITY (left arm  axillary painful, tiny lymph node) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Hypertension since 2014. Concurrent medical conditions included Drug allergy (Tramadol). Concomitant products included CHLORDIAZEPOXIDE, CLIDINIUM BROMIDE (LIBRAX [CHLORDIAZEPOXIDE;CLIDINIUM BROMIDE]) for Anxiety, VITAMIN D [VITAMIN D NOS] and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 24-Dec-2020 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2020, the patient experienced PAIN IN EXTREMITY (left arm  axillary painful, tiny lymph node). On 30-Dec-2020 at 7:00 PM, the patient experienced VACCINATION SITE LYMPHADENOPATHY (axillary swelling in the arm where he receive the injection). On 20-Jan-2021, VACCINATION SITE LYMPHADENOPATHY (axillary swelling in the arm where he receive the injection) and PAIN IN EXTREMITY (left arm  axillary painful, tiny lymph node) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE LYMPHADENOPATHY (axillary swelling in the arm where he receive the injection) and PAIN IN EXTREMITY (left arm  axillary painful, tiny lymph node) to be possibly related.    Concomitant medications were not provided.  Treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No specific follow-up information recorded. This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Jan-2021. The most recent information was received on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (axillary swelling in the arm where he receive the injection) and PAIN IN EXTREMITY (left arm  axillary painful, tiny lymph node) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Hypertension since 2014. Concurrent medical conditions included Drug allergy (Tramadol). Concomitant products included CHLORDIAZEPOXIDE, CLIDINIUM BROMIDE (LIBRAX [CHLORDIAZEPOXIDE;CLIDINIUM BROMIDE]) for Anxiety, VITAMIN D [VITAMIN D NOS] and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 24-Dec-2020 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2020, the patient experienced PAIN IN EXTREMITY (left arm  axillary painful, tiny lymph node). On 30-Dec-2020 at 7:00 PM, the patient experienced VACCINATION SITE LYMPHADENOPATHY (axillary swelling in the arm where he receive the injection). On 20-Jan-2021, VACCINATION SITE LYMPHADENOPATHY (axillary swelling in the arm where he receive the injection) and PAIN IN EXTREMITY (left arm  axillary painful, tiny lymph node) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE LYMPHADENOPATHY (axillary swelling in the arm where he receive the injection) and PAIN IN EXTREMITY (left arm  axillary painful, tiny lymph node) to be possibly related.    Concomitant medications were not provided.  Treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No specific follow-up information recorded.